🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11805+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11805 recruiting trials

NARecruitingNCT06313827

e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population

🏥 University of Valencia📍 1 site📅 Started Oct 2024View details ↗
Phase 2Enrolling by InvitationNCT06657859

Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients

👨‍⚕️ Chief Medical Officer, Glycomine, Inc.📍 2 sites📅 Started Sep 2024View details ↗
NAEnrolling by InvitationNCT06444282

Emergency Care Action Plans for Infants with Medical Complexity

👨‍⚕️ Christian D Pulcini, MD, MEd, MPH, University of Vermont Larner College of Medicine, University of Vermont Medical Center📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06863857

Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer

👨‍⚕️ Francesco Massari, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 2 sites📅 Started Sep 2024View details ↗
RecruitingNCT06908746

Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A Retrospective Study on Etiology of Liver Failure and Their Complications

👨‍⚕️ Rita Jacobs, Dr., Antwerp Univesity Hospital📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06626243

Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

🏥 Scientific Institute San Raffaele📍 6 sites📅 Started Sep 2024View details ↗
Phase 1RecruitingNCT06414434

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

👨‍⚕️ Michael Wagner, MD, Dana-Farber Cancer Institute📍 2 sites📅 Started Sep 2024View details ↗
Phase 4RecruitingNCT06609304

Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

🏥 Zhengzhou University📍 1 site📅 Started Sep 2024View details ↗
Phase 3RecruitingNCT06660992

A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

🏥 Haisco Pharmaceutical Group Co., Ltd.📍 2 sites📅 Started Sep 2024View details ↗
NARecruitingNCT06584045

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)

🏥 Tongji Hospital📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT07213440

Identification of Early Markers for ALS

🏥 Institut National de la Santé Et de la Recherche Médicale, France📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06569498

Neoadjuvant Triple Therapy for Resectable HCC

🏥 Fujian Provincial Hospital📍 6 sites📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06044311

Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma

👨‍⚕️ Sakti Chakrabarti, MD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06421636

A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 26 sites📅 Started Sep 2024View details ↗
RecruitingNCT06592989

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

👨‍⚕️ Jiuliang Yan, M.D., Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06718127

Description of the Immune Response to Yellow Fever Vaccination

👨‍⚕️ Fabien Taieb, Dr, Institut Pasteur📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06602011

Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)

🏥 Fujian Provincial Hospital📍 6 sites📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06635681

Efficacy of Venetoclax Combined with Intensive Chemotherapy in Different Subgroups of AML

👨‍⚕️ Hui Wei, MD, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT05613452

Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer

👨‍⚕️ Jingfang Mao, PHD, Shanghai Proton and Heavy Ion Center📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06317649

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

👨‍⚕️ Jessica K Altman, ECOG-ACRIN Cancer Research Group📍 220 sites📅 Started Sep 2024View details ↗
← PreviousPage 230 of 591Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →